Diverse epigenomic mechanisms underpin transcriptional dysregulation in Polycomb-altered acute myeloid leukemia
Cosmin TudoseiD, Luke JonesiD, Theodora-Ioana GrosuiD, Marie-Claire FitzgeraldiD, Noura MaziakiD, Rebecca E. LingiD, Anindita RoyiD, Juan M. VaquerizasiD, Colm J. RyaniD, Jonathan BondiD
Abstract
BackgroundPolycomb Repressive Complex 2 (PRC2) modulates chromatin accessibility and architecture to direct tissue-specific gene expression. PRC2 function is frequently altered in cancer by loss-of-function mutation or deletion, but the downstream effects on transcriptional regulation are incompletely understood. ResultsTo gain insights into these mechanisms, we performed a holistic analysis of epigenomic and transcriptional changes in an isogenic model of acute myeloid leukemia (AML) with heterozygous EZH2 deletion that mimics reduced PRC2 function in patient leukemias. PRC2-depleted cells had diverse gene expression changes, including a bias towards more immature monocyte-lineage transcriptional signatures. PRC2 depletion also correlated with marked increases in chromatin accessibility genome-wide, with 10-45% increases in ATAC-seq peaks in EZH2+/- clones. These changes were accompanied by decreased H3K27me3 and increased H3K27ac levels in CUT+RUN assays that were incompletely linked to transcriptional activity. Despite these generalised changes, 3D chromatin architecture assessed by Hi-C was largely maintained, with H3K27me3 preferentially lost in regions with low DNA-DNA contact frequency. Surprisingly, some regions gained broad H3K27me3 domains at heavily compacted chromatin. We notably saw compartmentalisation changes upstream of the transcriptionally upregulated fetal hematopoiesis gene LIN28B in EZH2+/- cells, with corresponding activation of a LIN28B-specific transcriptional program, including upregulation of the CDK6 oncogene. These results correlated with EZH2+/- cell phenotype, including decreased cellular proliferation and increased resistance to CDK6 inhibitor palbociclib. ConclusionsOur findings suggest that PRC2 depletion pleiotropically affects AML transcriptional regulation to directly impact cell phenotype and treatment responsiveness, which may partially explain the aggressive biology seen in these cases.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Epigenetic vulnerabilities of leukemia harboring inactivating EZH2 mutations
M. Alqazzaz, G. Luciani, … D. Barsyte-Lovejoy·bioRxiv·Nov 20, 2023
- EZH2 inhibition results in genome-wide PRC2 redistribution
Chih-Chi Yuan, Ah‐Jung Jeon, … Patrick Trojer·bioRxiv·Dec 29, 2019
- A Methylation-Phosphorylation Switch Controls EZH2 Stability and Hematopoiesis
P. Guo, K. Rajawasam, … H. Zhang·bioRxiv·Feb 2, 2023
- AEBP2-Directed H3K27me2 Defines a Specific Vulnerability in EZH2-mutant Lymphoma
Daniel Angelov, James Nolan, … Adrian P. Bracken·bioRxiv·Oct 14, 2025
- EZH2 mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibition
P. Romero, L. Richart, … R. Margueron·bioRxiv·Jan 2, 2023
- Activation of automethylated PRC2 by dimerization on chromatin
P. V. Sauer, E. Pavlenko, … S. Poepsel·bioRxiv·Oct 12, 2023